Clinical Trial

Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The main objective of this study is to evaluate the efficacy and safety of IV FCM(ferric carboxymaltose) in patients with AGC receiving palliative chemotherapy. This study will also evaluate the effect of IV FCM on the treatment outcomes of palliative chemotherapy in patients with gastric cancer receiving fluoropyrimidine and platinum-based regimen in the same 1st-line palliative setting.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-01-26; most recent amendment 2026-04-02.
Status change: Not Yet Recruiting → Recruiting 2022-05-09
Trial Details
NCT Number NCT05226169
Lead Sponsor Asan Medical Center
Conditions Advanced Gastric Carcinoma
Enrollment 330 participants
Start Date 2022-04-29
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-03